Patent · US Active

AAV capsid polynucleotides and polypeptides and virions containing the same

US12286457B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 31, 2019
Grant dateApr 29, 2025
Priority date
Expiry dateJul 30, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to polypeptides derived from marsupial adeno-associated vims (AAV). The disclosure is also related to nucleic acid molecules encoding the polypeptides, and vectors comprising the nucleic acid molecules, and AAV vectors comprising the polypeptides. The disclosure also relates to uses of the nucleic acid molecules, polypeptides and AAV vectors, such as for capsid diversification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.